Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay News — ...
Traumatic optic nerve head avulsion and traumatic optic neuropathy are serious and can be visually devastating. Most cases have poor prognosis for visual recovery, leaving patients with minimal or no ...
Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden vision loss. The risk of developing non-arteritic anterior ischemic optic ...
The use of semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is not associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION) in patients with ...
Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...
The top read ophthalmology articles of 2025 focused on a variety of topics within the field, including links between ...
Recently reported findings indicate that cenegermin-bkbj ophthalmic solution (Oxervate; Dompé) may perform as an effective ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
Traumatic optic neuropathy is visual loss caused by trauma to the optic nerve. Injuries, classified as direct or indirect, are also characterized by location. Intracanalicular optic nerve injury is ...
Researchers found that among semaglutide users, the incidence rate of nonarteritic anterior ischemic optic neuropathy was 14.5 per 100,000 person-years. HealthDay News — For individuals with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback